April 22 - Breakingviews columnists discuss the pharma M&A machine’s bid for its rival and activist investor Bill Ackman’s unusual role in backing the proposed deal.
01:42
01:10
00:31
01:31
00:46
00:25
00:50
02:26
01:54
01:50
02:04
01:29
02:16
02:45
00:52
01:49
01:57
03:43
01:48
00:40
00:25
01:57
01:31
02:50
01:31
00:49
01:57
00:50
01:22
01:12
01:04
03:00
01:04
02:43
01:31
00:53
03:14
01:44
01:11
01:28
00:31
01:49
03:43
00:49
02:06
00:39
03:04
00:58
01:07
01:38
00:45
01:10
01:04
02:19
00:59
00:14
01:05
01:14
00:17
01:14
01:22
00:46
01:29
02:04
02:45
05:18
01:10
01:05
01:08
01:07
00:29
01:11
01:50
01:49
02:50
01:26
01:34
01:03
01:37
02:20
01:42
00:52
04:06
03:26
00:31
01:10
03:18
01:18
01:20
01:30
01:24
02:00
01:26
02:13
01:21
01:54
01:00
01:42
03:46
03:25
01:50
01:14
02:02
01:25
02:18
01:11
02:13
01:39
01:52
02:03
01:28
01:37
01:36
01:11
00:47
01:15
01:46
01:48
02:05
02:05